Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CBT | TGS |
|---|---|---|
| Price | $77.38 | $26.58 |
| Change today | ▲ 0.56% | ▲ 6.28% |
| Market cap | $4.00B | $4.00B |
| Return, 3 months | -11.0% | -9.7% |
| Return, year to date | +18.7% | -14.5% |
| Return, 1 year | +5.0% | +25.0% |
| P/E (TTM) | 21.7 | 11.7 |
| P/B | 2.5 | 1.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.36% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +6.0% | – |
| Analyst buy share | 33% | 100% |
| RSI (14) | 40 | 43 |
| 30-day volatility | 21.4% | 33.9% |
| Max drawdown, 1 year | -24.0% | -29.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
